Noble James (CIK 0001388000)

Latest company ownership

Shares held
710,711
Last filed at
Jul 1, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 29, 2020 Jun 2, 2020 Adaptimmune Therapeutics PLC Director Sell 5.0 -500,000 -100.00% $4.7M
Jan 13, 2020 Jan 15, 2020 Adaptimmune Therapeutics PLC Director Sell 5.0 -300,000 -100.00% $1.4M